Table 2.

Clinical characteristics of study patientsa

MenWomenBoth
Entire patient cohortn = 190n = 216n = 406
Age at last follow-up (yr)44 ± 1242 ± 1243 ± 12
Body mass index (kg/m2)27 ± 4.525 ± 5.626 ± 5.1
Mean BP (mmHg)100 ± 1197 ± 9.598 ± 10
Hypertension (%)706668
ACEI/ARBb (%)524850
Smoker (%)403235.5
Smoking (pack-years)7.2 ± 146.0 ± 126.6 ± 13
Ccr at last follow-up (ml/min per 1.73 m2)52 ± 4458 ± 4155 ± 43
Patients without ESRD at last follow-upn = 106n = 141n = 247
    age at last follow-up (yr)38 ± 1338 ± 1238 ± 12.6
    Ccr at last follow-up (ml/min per 1.73 m2)85 ± 3382 ± 2983 ± 31
Patients with ESRD at last follow-upn = 84n = 75n = 159
    age at ESRD (yr)50 ± 850 ± 1050 ± 9
    Ccr at ESRD (ml/min per 1.73 m2)10.5 ± 1.99.6 ± 2.610.1 ± 2.3
  • a Data expressed as mean ± SD or %. ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.

  • b ACEI or ARB in hypertensive patients.